H.R. 3536 · 115th Congress
To require persons who undertake Federally funded research and development of drugs to enter into reasonable pricing agreements with the Secretary of Health and Human Services.
- Stage
- In committee
- Sponsor
- Peter DeFazio
- Introduced
- 2017-07-28
- Latest action
- 2017-08-04 · Referred to the Subcommittee on Health.
Subjects
Health
Inflation and prices
Medical research
Health programs administration and funding
Health technology, devices, supplies
Research and development
Intellectual property
Drug safety, medical device, and laboratory regulation